Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$836M |
| 2 |
Microsoft
MSFT
|
+$748M |
| 3 |
Cigna
CI
|
+$560M |
| 4 |
3M
MMM
|
+$558M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$535M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$568M |
| 2 |
Zoom
ZM
|
+$557M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$516M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$479M |
| 5 |
Unity
U
|
+$476M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.72% |
| 2 | Healthcare | 11.35% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Communication Services | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Invesco S&P 500 Equal Weight Industrials ETF
RSPN
$1.08B
| $11.2M | ﹤0.01% |
360,855
-3,315
| -0.9% | -$113K |
|
2827
LSB Industries
LXU
$737M
| $11.2M | ﹤0.01% |
784,478
+527,271
| +205% | +$7.46M |
|
2828
Atara Biotherapeutics
ATRA
$72.9M
| $11.1M | ﹤0.01% |
117,957
-10,998
| -9% | -$1.24M |
|
2829
US Commodity Index
USCI
$375M
| $11.1M | ﹤0.01% |
216,901
+162,349
| +298% | +$8.72M |
|
|
DCPH
2830
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $11.1M | ﹤0.01% |
601,703
-305,493
| -34% | -$4.79M |
|
2831
Stagwell
STGW
$2.23B
| $11.1M | ﹤0.01% |
1,599,837
-241,810
| -13% | -$1.56M |
|
2832
GS ActiveBeta US Small Cap Equity ETF
GSSC
$1.11B
| $11.1M | ﹤0.01% |
219,624
+4,791
| +2% | +$267K |
|
2833
Editas Medicine
EDIT
$433M
| $11.1M | ﹤0.01% |
905,736
-164,717
| -15% | -$2.57M |
|
2834
Adtran
ADTN
$684M
| $11.1M | ﹤0.01% |
566,005
+241,274
| +74% | +$5.26M |
|
2835
Deluxe
DLX
$1.1B
| $11.1M | ﹤0.01% |
664,738
+53,097
| +9% | +$1.12M |
|
2836
CNA Financial
CNA
$13.8B
| $11.1M | ﹤0.01% |
299,744
-9,656
| -3% | -$393K |
|
2837
ProShares High Yield-Interest Rate Hedged ETF
HYHG
$194M
| $11.1M | ﹤0.01% |
191,529
+2,621
| +1% | +$154K |
|
2838
Sturm, Ruger & Co
RGR
$602M
| $11.1M | ﹤0.01% |
217,598
-937
| -0.4% | -$54.1K |
|
|
EDD
2839
Morgan Stanley Emerging Markets Domestic Debt Fund
EDD
$372M
| $11M | ﹤0.01% |
2,744,355
-4,404
| -0.2% | -$19.3K |
|
2840
Aurinia Pharmaceuticals
AUPH
$2.06B
| $11M | ﹤0.01% |
1,467,029
-1,423,875
| -49% | -$12.3M |
|
|
PR
2841
Permian Resources
PR
$18B
| $11M | ﹤0.01% |
1,621,868
-628,509
| -28% | -$4.34M |
|
2842
Fulgent Genetics
FLGT
$511M
| $11M | ﹤0.01% |
289,287
+47,227
| +20% | +$2.37M |
|
2843
LeMaitre Vascular
LMAT
$1.88B
| $11M | ﹤0.01% |
217,442
+12,791
| +6% | +$639K |
|
2844
iRhythm Holdings
IRTC
$4.17B
| $11M | ﹤0.01% |
87,950
-181,837
| -67% | -$26.3M |
|
|
VLRS
2845
Controladora Vuela Compania de Aviacion
VLRS
$906M
| $11M | ﹤0.01% |
1,575,615
+28,296
| +2% | +$265K |
|
2846
Ternium
TX
$10.6B
| $11M | ﹤0.01% |
401,809
+3,685
| +0.9% | +$118K |
|
2847
iShares US Digital Infrastructure and Real Estate ETF
IDGT
$549M
| $11M | ﹤0.01% |
170,526
+12,152
| +8% | +$819K |
|
2848
Enovix
ENVX
$958M
| $11M | ﹤0.01% |
683,881
+346,553
| +103% | +$5.12M |
|
|
BIG
2849
DELISTED
Big Lots, Inc.
BIG
| $11M | ﹤0.01% |
702,622
-38,260
| -5% | -$823K |
|
2850
Vanguard Russell 3000 ETF
VTHR
$4.88B
| $11M | ﹤0.01% |
67,986
-2,115
| -3% | -$378K |
|
Similar funds
Morgan Stanley's Q3 2022 Portfolio in Review
As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
- Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
- Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
- Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
- Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
- Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.
Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.